Monday, August 29, 2022 5:10:57 PM
Atlnsider, concur that many holders are tired and anxious. You could probably add frustration to that. Some will sell just to break ever or make a small profit, and that's understandable, given the years it's taken to get to this point for DCVax-L, with another unknown period ahead before approval by regulators in the various countries, and yet another period of unknown length before the more promising treatment, DCL-Direct can go through the testing and approval process. Others, if their average cost is a dollar or less may sell enough at $3 or $5 to recover the cost of their investment, and the number left become playing with house money. Not a bad idea. Sound advice. Buffet, Cramer and well-known financial figures others support it, and it does make sense.
Let's face it, this hasn't a good investment for many. Too many other opportunities you could have taken advantage of and still have time to come back to NWBO at a price under $1. Helps if you're stubborn and have a patience beyond what most can muster. For myself, I'm still here for the long run, but have to admit I was originally anticipating a 5 or 10K, not a marathon +.
Let's face it, this hasn't a good investment for many. Too many other opportunities you could have taken advantage of and still have time to come back to NWBO at a price under $1. Helps if you're stubborn and have a patience beyond what most can muster. For myself, I'm still here for the long run, but have to admit I was originally anticipating a 5 or 10K, not a marathon +.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
